
Magellan Health, Inc. MGLN
Magellan Health, Inc. ROE Ratio 2011-2026 | MGLN
Annual ROE Ratio Magellan Health, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 20.45 | 4.0 | 1.88 | 8.63 | 7.08 | 2.95 | 7.0 | 10.83 | 14.85 | 15.34 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.45 | 1.88 | 9.3 |
ROE Ratio of other stocks in the Health care industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
12.9 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
14.28 | $ 275.12 | - | $ 72.5 B | ||
|
Triple-S Management Corporation
GTS
|
6.94 | - | 0.28 % | $ 847 M | ||
|
CVS Health Corporation
CVS
|
2.35 | $ 78.09 | - | $ 98.9 B | ||
|
UnitedHealth Group Inc.
UNH
|
12.05 | $ 313.0 | - | $ 284 B | ||
|
Centene Corporation
CNC
|
-33.45 | $ 37.47 | - | $ 18.5 B | ||
|
Molina Healthcare
MOH
|
11.6 | $ 149.98 | - | $ 7.92 B | ||
|
NovoCure Limited
NVCR
|
-40.01 | $ 10.72 | - | $ 1.19 B | ||
|
Humana
HUM
|
6.73 | $ 198.23 | - | $ 23.9 B |